🇫🇮 Finland Country × Condition
chronic subdural hematoma Clinical Trials in Finland
Active clinical trials for chronic subdural hematoma with research sites in Finland. All data sourced live from ClinicalTrials.gov — updated daily.
Active Trials: 2 // Recruiting: 2 // Updated: Daily
Total Trials
2
Recruiting Now
2
Country
🇫🇮 Finland
Active Trials in Finland (2)
NCT07740239
Recruiting
A COhort Study on Factors Leading to Vulnerability in Adult Patients With Serious Medical cOnditionS: the COSMOS-I Trial
Enrollment
2,050 pts
Country
🇫🇮 Finland
Tampere University Hospital
View Trial → NCT06696079
Recruiting
Restarting Early Versus Later Anticoagulation for Chronic Subdural Hematoma With Atrial Fibrillation
Enrollment
332 pts
Country
🇫🇮 Finland
Rahul Raj
View Trial → Frequently Asked Questions
How many chronic subdural hematoma clinical trials are active in Finland?
There are currently 2 active clinical trials for chronic subdural hematoma with sites in Finland, of which 2 are actively recruiting patients.
How can I join a chronic subdural hematoma clinical trial in Finland?
To join a chronic subdural hematoma clinical trial in Finland, select a recruiting trial below and check the eligibility criteria. Contact the trial's principal investigator or the listed site in Finland directly. All trials listed here are sourced from ClinicalTrials.gov, the official U.S. registry of clinical studies.
What phases are chronic subdural hematoma trials in Finland?
Active chronic subdural hematoma trials in Finland span multiple phases. Phase I trials test safety, Phase II test efficacy, and Phase III compare against standard treatments in larger patient populations.
ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer · Last Reviewed: November 2026 · Data Methodology